Read + Share
Amedeo Smart
Independent Medical Education
Noji R, Kano Y, Hirai H, Onishi I, et al. MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma. Oral Oncol 2021;124:105666.PMID: 34896892
Email
LinkedIn
Facebook
Twitter
Privacy Policy